May 2020 – Page 4 – Retraction Watch

Before we present this week’s Weekend Reads, a question: Do you enjoy our weekly roundup? If so, we could really use your help. Would you consider a tax-deductible donation to support Weekend Reads, and our daily work? Thanks in advance.

Sending thoughts to our readers and wishing them the best in this uncertain time.

The week at Retraction Watch featured:

the correction of an influential paper on COVID-19 because it cited a withdrawn preprint;
the retraction of a paper on gender dysphoria following a petition signed by 900 critics
20 expressions of concern for papers by a doctor who ran afoul of the FDA;
the return of the peer review bandits.

How many papers about COVID-19 have been retracted? We’ve been keeping track, as part of our database. Here’s our frequently updated list.

Here’s what was happening elsewhere:

Carlo Croce, the prolific cancer researcher at The Ohio State University (OSU) with a penchant for hiring — and then losing — lawyers to sue those who displease him, has lost an 10th paper to retraction.

Croce, who in addition to the 10 retractions also has three expressions of concern and 18 corrections for his work, unsuccessfully sued the New York Times for defamation after the newspaper reported on misconduct allegations against him. He has also sued OSU — also unsuccessfully — to force them to restore him as chair of the Department of Cancer Biology and Genetics.

Apparently, Croce and his co-author thought that a correction to the newly retracted article was necessary because of “improper reuse of text from previous articles.” The journal, however, felt differently.

Month: May 2020

Weekend reads: Retracted COVID-19 papers; a coronavirus study kept under wraps; Harvard and Jeffrey Epstein

Litigious OSU cancer researcher earns his 10th retraction

Share this:

Share this: